{
 "drug": "Elbasvir; Grazoprevir Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/17/2025",
 "dayN": 312,
 "cat": "Antiviral",
 "companies": [
  "Merck Sharp & Dohme LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/17/2025",
   "update_type": "New",
   "initial_posting_date": "10/17/2025",
   "package_ndc": "0006-3074-02",
   "generic_name": "Elbasvir; Grazoprevir Tablet",
   "contact_info": "800-672-6372",
   "related_info": "To be discontinued December 1, 2025",
   "openfda": {
    "application_number": [
     "NDA208261"
    ],
    "brand_name": [
     "ZEPATIER"
    ],
    "generic_name": [
     "ELBASVIR AND GRAZOPREVIR"
    ],
    "manufacturer_name": [
     "Merck Sharp & Dohme LLC"
    ],
    "product_ndc": [
     "0006-3074"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ELBASVIR",
     "GRAZOPREVIR ANHYDROUS"
    ],
    "rxcui": [
     "1734636",
     "1734642"
    ],
    "spl_id": [
     "227ae348-5f6f-44d8-a6dc-103e63d28102"
    ],
    "spl_set_id": [
     "164dc02a-9180-426a-b8b5-04ab39d2bbd4"
    ],
    "package_ndc": [
     "0006-3074-01",
     "0006-3074-02"
    ],
    "nui": [
     "N0000191256",
     "N0000190113",
     "N0000182638",
     "N0000182639",
     "N0000190114"
    ],
    "pharm_class_epc": [
     "Hepatitis C Virus NS5A Inhibitor [EPC]",
     "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Breast Cancer Resistance Protein Inhibitors [MoA]",
     "HCV NS3/4A Protease Inhibitors [MoA]",
     "Cytochrome P450 3A Inhibitors [MoA]"
    ],
    "unii": [
     "632L571YDK",
     "8YE81R1X1J"
    ]
   },
   "update_date": "10/17/2025",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Tablet",
   "presentation": "Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02)",
   "company_name": "Merck Sharp & Dohme LLC",
   "status": "To Be Discontinued"
  }
 ]
}